194 related articles for article (PubMed ID: 31536893)
1. Sulfide, sulfoxide and sulfone bridged acyclic nucleoside phosphonates as inhibitors of the Plasmodium falciparum and human 6-oxopurine phosphoribosyltransferases: Synthesis and evaluation.
Klejch T; Keough DT; Chavchich M; Travis J; Skácel J; Pohl R; Janeba Z; Edstein MD; Avery VM; Guddat LW; Hocková D
Eur J Med Chem; 2019 Dec; 183():111667. PubMed ID: 31536893
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Evaluation of Novel Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium falciparum and Human 6-Oxopurine Phosphoribosyltransferases.
Kaiser MM; Hocková D; Wang TH; Dračínský M; Poštová-Slavětínská L; Procházková E; Edstein MD; Chavchich M; Keough DT; Guddat LW; Janeba Z
ChemMedChem; 2015 Oct; 10(10):1707-23. PubMed ID: 26368337
[TBL] [Abstract][Full Text] [Related]
3. Aza-acyclic nucleoside phosphonates containing a second phosphonate group as inhibitors of the human, Plasmodium falciparum and vivax 6-oxopurine phosphoribosyltransferases and their prodrugs as antimalarial agents.
Keough DT; Hocková D; Janeba Z; Wang TH; Naesens L; Edstein MD; Chavchich M; Guddat LW
J Med Chem; 2015 Jan; 58(2):827-46. PubMed ID: 25494538
[TBL] [Abstract][Full Text] [Related]
4. Acyclic Nucleoside Phosphonates Containing 9-Deazahypoxanthine and a Five-Membered Heterocycle as Selective Inhibitors of Plasmodial 6-Oxopurine Phosphoribosyltransferases.
Kaiser MM; Baszczyňski O; Hocková D; Poštová-Slavětínská L; Dračínský M; Keough DT; Guddat LW; Janeba Z
ChemMedChem; 2017 Jul; 12(14):1133-1141. PubMed ID: 28628279
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of purine N9-[2-hydroxy-3-O-(phosphonomethoxy)propyl] derivatives and their side-chain modified analogs as potential antimalarial agents.
Krečmerová M; Dračínský M; Hocková D; Holý A; Keough DT; Guddat LW
Bioorg Med Chem; 2012 Feb; 20(3):1222-30. PubMed ID: 22249123
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of branched 9-[2-(2-phosphonoethoxy)ethyl]purines as a new class of acyclic nucleoside phosphonates which inhibit Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase.
Hocková D; Holý A; Masojídková M; Keough DT; de Jersey J; Guddat LW
Bioorg Med Chem; 2009 Sep; 17(17):6218-32. PubMed ID: 19666228
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel N-branched acyclic nucleoside phosphonates as potent and selective inhibitors of human, Plasmodium falciparum and Plasmodium vivax 6-oxopurine phosphoribosyltransferases.
Hocková D; Keough DT; Janeba Z; Wang TH; de Jersey J; Guddat LW
J Med Chem; 2012 Jul; 55(13):6209-23. PubMed ID: 22725979
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Evaluation of Asymmetric Acyclic Nucleoside Bisphosphonates as Inhibitors of Plasmodium falciparum and Human Hypoxanthine-Guanine-(Xanthine) Phosphoribosyltransferase.
Špaček P; Keough DT; Chavchich M; Dračínský M; Janeba Z; Naesens L; Edstein MD; Guddat LW; Hocková D
J Med Chem; 2017 Sep; 60(17):7539-7554. PubMed ID: 28813147
[TBL] [Abstract][Full Text] [Related]
9. Acyclic nucleoside phosphonates containing a second phosphonate group are potent inhibitors of 6-oxopurine phosphoribosyltransferases and have antimalarial activity.
Keough DT; Špaček P; Hocková D; Tichý T; Vrbková S; Slavětínská L; Janeba Z; Naesens L; Edstein MD; Chavchich M; Wang TH; de Jersey J; Guddat LW
J Med Chem; 2013 Mar; 56(6):2513-26. PubMed ID: 23448281
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 9-phosphonoalkyl and 9-phosphonoalkoxyalkyl purines: evaluation of their ability to act as inhibitors of Plasmodium falciparum, Plasmodium vivax and human hypoxanthine-guanine-(xanthine) phosphoribosyltransferases.
Česnek M; Hocková D; Holý A; Dračínský M; Baszczyňski O; Jersey Jd; Keough DT; Guddat LW
Bioorg Med Chem; 2012 Jan; 20(2):1076-89. PubMed ID: 22178188
[TBL] [Abstract][Full Text] [Related]
11. N2'-Branched Acyclic Nucleoside Phosphonates Containing 9-Deazahypoxanthine as Inhibitors of Plasmodium falciparum 6-Oxopurine Phosphoribosyltransferase.
Vaňková K; Keough DT; Hocková D; Guddat LW; Janeba Z
ChemMedChem; 2023 Aug; 18(15):e202300211. PubMed ID: 37264975
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of symmetric acyclic nucleoside bisphosphonates as inhibitors of the Plasmodium falciparum, Plasmodium vivax and human 6-oxopurine phosphoribosyltransferases and the antimalarial activity of their prodrugs.
Špaček P; Keough DT; Chavchich M; Dračínský M; Janeba Z; Naesens L; Edstein MD; Guddat LW; Hocková D
Bioorg Med Chem; 2017 Aug; 25(15):4008-4030. PubMed ID: 28601510
[TBL] [Abstract][Full Text] [Related]
13. Nucleotide analogues containing a pyrrolidine, piperidine or piperazine ring: Synthesis and evaluation of inhibition of plasmodial and human 6-oxopurine phosphoribosyltransferases and in vitro antimalarial activity.
Frydrych J; Keough DT; Chavchich M; Travis J; Dračínský M; Edstein MD; Guddat LW; Hocková D; Janeba Z
Eur J Med Chem; 2021 Jul; 219():113416. PubMed ID: 33887682
[TBL] [Abstract][Full Text] [Related]
14. Acyclic immucillin phosphonates: second-generation inhibitors of Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase.
Hazleton KZ; Ho MC; Cassera MB; Clinch K; Crump DR; Rosario I; Merino EF; Almo SC; Tyler PC; Schramm VL
Chem Biol; 2012 Jun; 19(6):721-30. PubMed ID: 22726686
[TBL] [Abstract][Full Text] [Related]
15. The effect of novel [3-fluoro-(2-phosphonoethoxy)propyl]purines on the inhibition of Plasmodium falciparum, Plasmodium vivax and human hypoxanthine-guanine-(xanthine) phosphoribosyltransferases.
Baszczyňski O; Hocková D; Janeba Z; Holý A; Jansa P; Dračínský M; Keough DT; Guddat LW
Eur J Med Chem; 2013 Sep; 67():81-9. PubMed ID: 23850568
[TBL] [Abstract][Full Text] [Related]
16. Acyclic phosph(on)ate inhibitors of Plasmodium falciparum hypoxanthine-guanine-xanthine phosphoribosyltransferase.
Clinch K; Crump DR; Evans GB; Hazleton KZ; Mason JM; Schramm VL; Tyler PC
Bioorg Med Chem; 2013 Sep; 21(17):5629-46. PubMed ID: 23810424
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hypoxanthine-guanine phosphoribosyltransferase by acyclic nucleoside phosphonates: a new class of antimalarial therapeutics.
Keough DT; Hocková D; Holý A; Naesens LM; Skinner-Adams TS; Jersey Jd; Guddat LW
J Med Chem; 2009 Jul; 52(14):4391-9. PubMed ID: 19527031
[TBL] [Abstract][Full Text] [Related]
18. Lead compounds for antimalarial chemotherapy: purine base analogs discriminate between human and P. falciparum 6-oxopurine phosphoribosyltransferases.
Keough DT; Skinner-Adams T; Jones MK; Ng AL; Brereton IM; Guddat LW; de Jersey J
J Med Chem; 2006 Dec; 49(25):7479-86. PubMed ID: 17149876
[TBL] [Abstract][Full Text] [Related]
19. Antimalarial activity of prodrugs of N-branched acyclic nucleoside phosphonate inhibitors of 6-oxopurine phosphoribosyltransferases.
Hocková D; Janeba Z; Naesens L; Edstein MD; Chavchich M; Keough DT; Guddat LW
Bioorg Med Chem; 2015 Sep; 23(17):5502-10. PubMed ID: 26275679
[TBL] [Abstract][Full Text] [Related]
20. 6-oxopurine phosphoribosyltransferase: a target for the development of antimalarial drugs.
de Jersey J; Holý A; Hocková D; Naesens L; Keough DT; Guddat LW
Curr Top Med Chem; 2011; 11(16):2085-102. PubMed ID: 21619515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
